Immunohistochemical staining (using CD10, bcl-6, and IRF4/MUM1) and gene expression profiling are used to classify DLBCL by cell of origin into the germinal center B-cell subtype and activated B-cell/non-germinal center B-cell subtype [3]. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.